IZON Technologies, LLC, Grants Exclusive Glasses-Free 3D License to W.A. Howell and Associates for Mobile Healthcare Devices
MELD Systems Set to Develop and Manufacture
ORLANDO, Fla., Jan. 26, 2015 /PRNewswire-HISPANIC PR WIRE/ — IZON® Technologies, LLC, has granted an exclusive license for its glasses-free 3D technology to W.A. Howell & Associates, LLP, Newport Beach, Ca. According to Joseph DiFrancesco, CEO of IZON, based in Orlando, the license is applicable to healthcare software development for portable medical devices such as tablets and mobile phones.
W.A. Howell stated: “IZON’s proprietary technology is a real game changer for us by providing the healthcare industry the only mobile and tablet devices that give physicians the ability to analyze and prescribe treatment remotely employing powerful 3D technology— and forever eliminating the need for glasses. We’re anticipating full certification under the Affordable Care Act and its Meaningful Use demands.”
Howell has licensed MELD Systems, Inc., a leading software development company located in Denver and Bangalore, India, to build its 3D mobile product line.
“We recognize the significance that IZON’s 3D technology brings to the healthcare market,” said MELD Systems CEO Thomas Levin. “This technology is a critical tool for 21st century healthcare delivery and will be in high demand globally by many healthcare entities such as universities, hospitals, clinics, private practices, and laboratories.”
“IZON is pleased to be in business with W.A. Howell and MELD Systems,” stated DiFrancesco. “We anticipate a major win through this partnership, and look forward to a successful rollout later this year.”
IZON also provides glasses-free 50″ and 65″ Ultra HD 3D televisions that play stereo content up to 2160P for markets including digital displays for hotels, retail stores, shopping malls, sports arenas, fast food outlets, schools and universities, and casinos.
IZON will be at ICE 2015 in London for meetings with casino owners and gaming manufacturers February 4 and 5.
Notice:
This is not an offering. The information contained in this press release is being disseminated for informational purposes only and may contain forward looking statements that may or may not occur. Investors should not invest without seeking the advice of their financial advisor.
